شیمی دارویی داروپخش
دشیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/07/07 Fiscal Year 2026/03/2012 Month | 2025/05/19 Fiscal Year 2025/03/2012 Month | 2024/05/18 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 310.872 Billion | 756.578 Billion | 93.789 Billion | |
Trade Receivables | 8.042 Trillion | 7.368 Trillion | 6.02 Trillion | |
Prepayments | 3.333 Trillion | - | 1.27 Trillion | |
Orders & Prepayments | - | 1.666 Trillion | - | |
Raw Materials & Packaging Inventory | 1.053 Trillion | 796.629 Billion | 787.045 Billion | |
Work-in-Progress Inventory | 445.732 Billion | 526.006 Billion | 1.104 Trillion | |
Finished Goods Inventory | 471.584 Billion | 1.245 Trillion | 1.234 Trillion | |
Spare Parts Inventory | 89.076 Billion | 89.505 Billion | 85.063 Billion | |
Goods in Transit | - | 78.098 Billion | 462.899 Billion | |
Our Goods on Consignment with Others | 6.283 Billion | - | - | |
Other Inventories | 105.089 Billion | 147.205 Billion | 122.634 Billion | |
Inventories | 2.171 Trillion | 2.883 Trillion | 3.796 Trillion | |
Total Current Assets | 13.857 Trillion | 12.673 Trillion | 11.181 Trillion | |
Long-Term Investments | 1.163 Billion | 1.109 Billion | 177 Million | |
Intangible Assets | 80.764 Billion | 37.893 Billion | 37.759 Billion | |
Property, Plant & Equipment | 1.091 Trillion | 19.573 Trillion | 992.301 Billion | |
Net Fixed Assets | 1.091 Trillion | 19.573 Trillion | 992.301 Billion | |
Total Non-Current Assets | 1.173 Trillion | 19.612 Trillion | 1.03 Trillion | |
Total Assets | 15.03 Trillion | 32.285 Trillion | 12.211 Trillion | |
Trade Payables | 3.193 Trillion | 3.064 Trillion | 2.213 Trillion | |
Advances Received | 92.419 Billion | 801 Million | 321 Million | |
Income Tax Provision | 411.679 Billion | 580.576 Billion | 1.097 Trillion | |
Proposed & Payable Dividends | 4.588 Trillion | 4.185 Trillion | 2.189 Trillion | |
Current Borrowings | 2.022 Trillion | 2.483 Trillion | 1.45 Trillion | |
Total Current Liabilities | 10.307 Trillion | 10.313 Trillion | 6.95 Trillion | |
Long-Term Borrowings | - | - | 57.222 Billion | |
Employee Termination Benefits Provision | 564.666 Billion | 372.373 Billion | 262.766 Billion | |
Total Non-Current Liabilities | 564.666 Billion | 372.373 Billion | 319.988 Billion | |
Total Liabilities | 10.871 Trillion | 10.686 Trillion | 7.27 Trillion | |
Capital | 900 Billion | 900 Billion | 900 Billion | |
Retained Earnings | 3.214 Trillion | 2.207 Trillion | 4.041 Trillion | |
Legal Reserve | 90 Billion | 90 Billion | 90 Billion | |
Share Premium Reserve | -45.178 Billion | -45.178 Billion | -89.224 Billion | |
Total Equity | 4.159 Trillion | 21.599 Trillion | 4.941 Trillion | |
Total Liabilities & Equity | 15.03 Trillion | 32.285 Trillion | 12.211 Trillion | |
Approved Capital | 900 Billion | 900 Billion | 900 Billion | |
Approved Retained Earnings | 2.314 Trillion | 1.348 Trillion | 1.386 Trillion | |
Approved Legal Reserve | 90 Billion | 90 Billion | 90 Billion | |
Total Approved Equity (at AGM) | 3.304 Trillion | 2.338 Trillion | 2.376 Trillion | |
Revaluation Surplus of Property, Plant and Equipment | - | 18.447 Trillion | - |